159 related articles for article (PubMed ID: 12431852)
1. Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study.
Rauch SL; Shin LM; Dougherty DD; Alpert NM; Fischman AJ; Jenike MA
Neuropsychopharmacology; 2002 Nov; 27(5):782-91. PubMed ID: 12431852
[TBL] [Abstract][Full Text] [Related]
2. Predictors of treatment response to fluvoxamine in obsessive-compulsive disorder: an fMRI study.
Sanematsu H; Nakao T; Yoshiura T; Nabeyama M; Togao O; Tomita M; Masuda Y; Nakatani E; Nakagawa A; Kanba S
J Psychiatr Res; 2010 Mar; 44(4):193-200. PubMed ID: 19758599
[TBL] [Abstract][Full Text] [Related]
3. Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder.
Rauch SL; Dougherty DD; Cosgrove GR; Cassem EH; Alpert NM; Price BH; Nierenberg AA; Mayberg HS; Baer L; Jenike MA; Fischman AJ
Biol Psychiatry; 2001 Nov; 50(9):659-67. PubMed ID: 11704072
[TBL] [Abstract][Full Text] [Related]
4. Cerebral glucose metabolism in obsessive-compulsive hoarding.
Saxena S; Brody AL; Maidment KM; Smith EC; Zohrabi N; Katz E; Baker SK; Baxter LR
Am J Psychiatry; 2004 Jun; 161(6):1038-48. PubMed ID: 15169692
[TBL] [Abstract][Full Text] [Related]
5. Neurocircuitry of disgust and anxiety in obsessive-compulsive disorder: a positron emission tomography study.
Stein DJ; Arya M; Pietrini P; Rapoport JL; Swedo SE
Metab Brain Dis; 2006 Sep; 21(2-3):267-77. PubMed ID: 16850255
[TBL] [Abstract][Full Text] [Related]
6. Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine.
Ho Pian KL; van Megen HJ; Ramsey NF; Mandl R; van Rijk PP; Wynne HJ; Westenberg HG
Psychiatry Res; 2005 Feb; 138(2):89-97. PubMed ID: 15766633
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
[TBL] [Abstract][Full Text] [Related]
8. Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study.
Nakao T; Nakagawa A; Yoshiura T; Nakatani E; Nabeyama M; Yoshizato C; Kudoh A; Tada K; Yoshioka K; Kawamoto M; Togao O; Kanba S
Biol Psychiatry; 2005 Apr; 57(8):901-10. PubMed ID: 15820711
[TBL] [Abstract][Full Text] [Related]
9. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography.
Rauch SL; Jenike MA; Alpert NM; Baer L; Breiter HC; Savage CR; Fischman AJ
Arch Gen Psychiatry; 1994 Jan; 51(1):62-70. PubMed ID: 8279930
[TBL] [Abstract][Full Text] [Related]
10. Regional cerebral blood flow abnormalities in early-onset obsessive-compulsive disorder: an exploratory SPECT study.
Busatto GF; Buchpiguel CA; Zamignani DR; Garrido GE; Glabus MF; Rosario-Campos MC; Castro CC; Maia A; Rocha ET; McGuire PK; Miguel EC
J Am Acad Child Adolesc Psychiatry; 2001 Mar; 40(3):347-54. PubMed ID: 11288777
[TBL] [Abstract][Full Text] [Related]
11. Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression.
Saxena S; Brody AL; Ho ML; Zohrabi N; Maidment KM; Baxter LR
Am J Psychiatry; 2003 Mar; 160(3):522-32. PubMed ID: 12611834
[TBL] [Abstract][Full Text] [Related]
12. Parental obsessive-compulsive disorder as a prognostic factor in a year long fluvoxamine treatment in childhood and adolescent obsessive-compulsive disorder.
Yaryura-Tobias JA; Grunes MS; Walz J; Neziroglu F
Int Clin Psychopharmacol; 2000 May; 15(3):163-8. PubMed ID: 10870874
[TBL] [Abstract][Full Text] [Related]
13. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder.
Saxena S; Brody AL; Maidment KM; Dunkin JJ; Colgan M; Alborzian S; Phelps ME; Baxter LR
Neuropsychopharmacology; 1999 Dec; 21(6):683-93. PubMed ID: 10633474
[TBL] [Abstract][Full Text] [Related]
14. Changes after behavior therapy among responsive and nonresponsive patients with obsessive-compulsive disorder.
Yamanishi T; Nakaaki S; Omori IM; Hashimoto N; Shinagawa Y; Hongo J; Horikoshi M; Tohyama J; Akechi T; Soma T; Iidaka T; Furukawa TA
Psychiatry Res; 2009 Jun; 172(3):242-50. PubMed ID: 19346109
[TBL] [Abstract][Full Text] [Related]
15. MR perfusion-weighted imaging and quantitative analysis of cerebral hemodynamics with symptom provocation in unmedicated patients with obsessive-compulsive disorder.
Chen XL; Xie JX; Han HB; Cui YH; Zhang BQ
Neurosci Lett; 2004 Nov; 370(2-3):206-11. PubMed ID: 15488324
[TBL] [Abstract][Full Text] [Related]
16. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
[TBL] [Abstract][Full Text] [Related]
17. Prazosin addition to fluvoxamine: A preclinical study and open clinical trial in OCD.
Feenstra MGP; Klompmakers A; Figee M; Fluitman S; Vulink N; Westenberg HGM; Denys D
Eur Neuropsychopharmacol; 2016 Feb; 26(2):310-319. PubMed ID: 26712326
[TBL] [Abstract][Full Text] [Related]
18. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.
Saxena S; Brody AL; Ho ML; Alborzian S; Maidment KM; Zohrabi N; Ho MK; Huang SC; Wu HM; Baxter LR
Arch Gen Psychiatry; 2002 Mar; 59(3):250-61. PubMed ID: 11879163
[TBL] [Abstract][Full Text] [Related]
19. A functional neuroimaging investigation of deep brain stimulation in patients with obsessive-compulsive disorder.
Rauch SL; Dougherty DD; Malone D; Rezai A; Friehs G; Fischman AJ; Alpert NM; Haber SN; Stypulkowski PH; Rise MT; Rasmussen SA; Greenberg BD
J Neurosurg; 2006 Apr; 104(4):558-65. PubMed ID: 16619660
[TBL] [Abstract][Full Text] [Related]
20. Brain SPECT imaging in children and adolescents with obsessive-compulsive disorder.
Castillo AR; Buchpiguel CA; de Araújo LA; Castillo JC; Asbahr FR; Maia AK; de Oliveira Latorre MR
J Neural Transm (Vienna); 2005 Aug; 112(8):1115-29. PubMed ID: 15666040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
